Molecular Markers Distinguishing Early‐Stage Mycosis Fungoides From Atopic Dermatitis Skin Lesions
Experimental Dermatology · 2026
DOI: 10.1111/exd.70240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Dermatology, 2026. Verfasst von Brandon D Ng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Icahn School of Medicine, New York, USA. Hauptthemen laut MEDLINE: Mycosis Fungoides, Dermatitis, Atopic, Skin Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NCATS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Mycosis fungoides (MF) is the most common type of primary cutaneous T‐cell lymphoma, a disease characterized by malignant T cells that home to the skin. In early stages, clinical presentation is often indistinguishable from benign chronic inflammatory skin diseases such as atopic dermatitis (AD), posing a challenge for proper diagnosis and treatment. Previous studies have established that MF is characterized by the expansion of a single T‐cell clone, whereas benign skin conditions are polyclonal in nature. In this study, we aimed to use single‐cell RNA sequencing data to detect distinct transcriptomic features of early‐stage MF in comparison to AD skin. In early‐stage MF, we observed gene expression differences in cells of both the stroma and the immune system, with keratinocytes exhibiting increased interferon response and proliferation ( STAT1 , ICAM1 , HLA‐DRA , GJB2 ), while fibroblasts displayed tumour‐associated programs ( CXCL2 , TNFAIP6 , CEBPD ). Myeloid cells exhibited expression of immunomodulatory genes ( RUNX3 , DDIT4 , IL4I1 ), and malignant T‐cells expressed exhaustion‐associated markers ( CXCL13 , SOCS3 , F2R , ETV1 ), as opposed to AD and healthy control samples. Thus, our results provide a novel insight into the immune‐stroma crosstalk in the tissue microenvironment of early‐stage MF vs. AD skin lesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Icahn School of Medicine, New York, USA.
- Department of Dermatology, Medical University of Vienna, Vienna, Austria.
ORCID-Profile: Brandon D Ng, Patrick M Brunner
Förderung
- NIAMS NIH HHS
- NCATS NIH HHS
- NIH HHS
- Icahn School of Medicine at Mount Sinai
- National Center for Advancing Translational Sciences
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Institutes of Health
Zitieren
APA
Ng, B. D., Whelan, C., Alkon, N., Kurowski, A., Jonak, C., & Brunner, P. M. (2026). Molecular Markers Distinguishing Early‐Stage Mycosis Fungoides From Atopic Dermatitis Skin Lesions. Experimental Dermatology. https://doi.org/10.1111/exd.70240
Vancouver
Ng BD, Whelan C, Alkon N, Kurowski A, Jonak C, Brunner PM. Molecular Markers Distinguishing Early‐Stage Mycosis Fungoides From Atopic Dermatitis Skin Lesions. Experimental Dermatology. 2026. doi:10.1111/exd.70240
BibTeX
@article{Ng2026,
author = {Ng, Brandon D and Whelan, Conor and Alkon, Natalia and Kurowski, Agata and Jonak, Constanze and Brunner, Patrick M},
title = {Molecular Markers Distinguishing Early‐Stage Mycosis Fungoides From Atopic Dermatitis Skin Lesions},
journal = {Experimental Dermatology},
year = {2026},
doi = {10.1111/exd.70240}
}
EUVIMED